நிறுவனம் ஆஃப் மருந்து அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் ஆஃப் மருந்து அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் ஆஃப் மருந்து அறிவியல் Today - Breaking & Trending Today

Lucknow University to get new faculty on Shaivism


Lucknow University to get new faculty on Shaivism
​ By
IANS
|
​ 88 Views
Lucknow University.. Image Source: IANS News
Lucknow, July 18 : The Academic Council of Lucknow University has approved setting up of a new faculty by upgrading the status of Abhinavagupt Institute of Aesthetics and Shaiva Philosophy.
The council also approved new courses from next session.
The Abhinavagupt Institute of Aesthetics and Shaiva Philosophy, named after the philosopher, mystic and aesthetician from Kashmir, was constituted in LU for research in Shaivism.
Till now, it was an autonomous institute, but now it will have faculty status. The institute will have more power and resources for teaching and research. It will run a full-fledged paper on Shaiva Philosophy and Aesthetics in MA (Sanskrit) course and conduct doctoral studies. ....

Uttar Pradesh , Institute Of Pharmaceutical Sciences , Abhinavagupt Institute Of Aesthetics , Academic Council Of Lucknow University , Academic Council , Lucknow University , Abhinavagupt Institute , Shaiva Philosophy , உத்தர் பிரதேஷ் , நிறுவனம் ஆஃப் மருந்து அறிவியல் , லக்னோ பல்கலைக்கழகம் , ஷைவா தத்துவம் ,

Researchers look at enhancing brain delivery of drugs to treat neurodegenerative diseases


King’s College London
New gel technology achieves enhanced brain delivery of a Parkinson’s Disease drug.
A team of researchers from the School of Cancer & Pharmaceutical Sciences at King’s, led by Professor Khuloud Al-Jamal, Head of Medicines Development at the Institute of Pharmaceutical Science, have been working collaboratively with researchers from the University of York to optimise the brain uptake of a new gel designed to treat Parkinson’s Disease.
Parkinson’s Disease is a debilitating and progressive neurodegenerative disease. Over 100,000 people live with the condition in the UK and it’s the fastest growing neurological condition in the world. The main symptoms of the disease are tremor, stiffness, and slowness of movement. ....

United Kingdom , City Of , David Smith , Julie Wang , Mazen Aly , Khuloud Al Jamal , School Of Cancer Pharmaceutical Sciences At King , King College London , Institute Of Pharmaceutical Science , School Of Cancer Pharmaceutical Sciences , University Of York , Head Of Medicines Development , Pharmaceutical Sciences , Professor Khuloud Al Jamal , Medicines Development , Pharmaceutical Science , Motor Neuron , Kings College London , Open Access , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , டேவிட் ஸ்மித் , ஜூலி வாங் , கிங் கல்லூரி லண்டன் , நிறுவனம் ஆஃப் மருந்து அறிவியல் , பள்ளி ஆஃப் புற்றுநோய் மருந்து அறிவியல் ,

Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript


Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Simulations Plus Inc (NASDAQ: SLP)
Popular Searches
Operator
Greetings and welcome to Simulations Plus Second Quarter Fiscal 2021 Financial Results Conference Call and Webinar. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Jeff Stanlis from HAYDEN IR. Thank you. Mr. Stanlis, you may now begin.SPONSORED:
10 stocks we like better than Simulations Plus, Inc. ....

United States , France General , Matt Hewitt , David Windley , Jeff Stanlis , Paul Watkins , Shawn Oconnor , Dilisym Renasym , Francois Brisebois , David Windley Jefferies , University Of North Carolina , Simulations Plus Inc , Translational Sciences , Brazilian Health Regulatory Agency , Motley Fool Simulations Plus Inc , Toxicological Research , University Of Pittsburgh Drug Discovery Institute , Francois Brisebois Oppenheimer Co , Renasym Consortium , Institute Of Pharmaceutical Sciences , National Center , Makerere University , Department Of Pharmacology , Exchange Commission , Matthew Hewitt Craig Hallum Capital Group , Health Canada ,